Research Paper Volume 17, Issue 5 pp 1313—1327
Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis
Figure 3. Cochrane risk-of-bias assessment tool for randomized trials version 2.